Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation
Conditions: Systemic Sclerosis; SARS-CoV 2 Vaccination Intervention: Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Coronavirus | Covid Vaccine | COVID-19 | Research | Respiratory Medicine | SARS | Scleroderma | Stem Cell Therapy | Stem Cells | Transplants | Vaccines